108 related articles for article (PubMed ID: 38785155)
1. Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).
Taylor J; Dubois F; Bergot E; Levallet G
Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38785155
[TBL] [Abstract][Full Text] [Related]
2. Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.
Zhang Y; Yan S; Li Y; Zhang J; Luo Y; Li P; Yang Y; Li Y; Huang Y; Wang E
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34505633
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA NSCLCAT1 increases non-small cell lung cancer cell invasion and migration through the Hippo signaling pathway by interacting with CDH1.
Zhao W; Zhang LN; Wang XL; Zhang J; Yu HX
FASEB J; 2019 Jan; 33(1):1151-1166. PubMed ID: 30148675
[TBL] [Abstract][Full Text] [Related]
4. Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non-small cell lung cancer cells.
Yao YH; Cui Y; Qiu XN; Zhang LZ; Zhang W; Li H; Yu JM
Chin J Cancer; 2016 Jun; 35():50. PubMed ID: 27266881
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacin E inhibits the Yes‑associated protein signaling pathway and suppresses brain metastasis of human non‑small cell lung cancer in a murine model.
Hsu PC; Tian B; Yang YL; Wang YC; Liu S; Urisman A; Yang CT; Xu Z; Jablons DM; You L
Oncol Rep; 2019 Aug; 42(2):697-707. PubMed ID: 31233205
[TBL] [Abstract][Full Text] [Related]
6. Excellent Outcomes with Radiosurgery for Multiple Brain Metastases in ALK and EGFR Driven Non-Small Cell Lung Cancer.
Robin TP; Camidge DR; Stuhr K; Nath SK; Breeze RE; Pacheco JM; Liu AK; Gaspar LE; Purcell WT; Doebele RC; Kavanagh BD; Rusthoven CG
J Thorac Oncol; 2018 May; 13(5):715-720. PubMed ID: 29269007
[TBL] [Abstract][Full Text] [Related]
7. Multiinstitutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases from non-small cell lung cancer (JLGK0901 study-NSCLC).
Shuto T; Akabane A; Yamamoto M; Serizawa T; Higuchi Y; Sato Y; Kawagishi J; Yamanaka K; Jokura H; Yomo S; Nagano O; Aoyama H
J Neurosurg; 2018 Dec; 129(Suppl1):86-94. PubMed ID: 30544291
[TBL] [Abstract][Full Text] [Related]
8. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
10. ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway.
Liu XF; Han Q; Rong XZ; Yang M; Han YC; Yu JH; Lin XY
Int J Oncol; 2020 May; 56(5):1175-1185. PubMed ID: 32319569
[TBL] [Abstract][Full Text] [Related]
11. Role of perilesional edema and tumor volume in the prognosis of non-small cell lung cancer (NSCLC) undergoing radiosurgery (SRS) for brain metastases.
Nardone V; Nanni S; Pastina P; Vinciguerra C; Cerase A; Correale P; Guida C; Giordano A; Tini P; Reginelli A; Cappabianca S; Pirtoli L
Strahlenther Onkol; 2019 Aug; 195(8):734-744. PubMed ID: 31123785
[TBL] [Abstract][Full Text] [Related]
12. β-Elemene enhances radiosensitivity in non-small-cell lung cancer by inhibiting epithelial-mesenchymal transition and cancer stem cell traits via Prx-1/NF-kB/iNOS signaling pathway.
Zou K; Li Z; Zhang Y; Mu L; Chen M; Wang R; Deng W; Zou L; Liu J
Aging (Albany NY); 2020 Dec; 13(2):2575-2592. PubMed ID: 33316778
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-103a Curtails the Stemness of Non-Small Cell Lung Cancer Cells by Binding OTUB1 via the Hippo Signaling Pathway.
Hu Z; Xiao D; Qiu T; Li J; Liu Z
Technol Cancer Res Treat; 2020; 19():1533033820971643. PubMed ID: 33174524
[TBL] [Abstract][Full Text] [Related]
14. Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers.
Liang H; Xu Y; Zhao J; Chen M; Wang M
Cancer Gene Ther; 2024 May; 31(5):652-666. PubMed ID: 38499647
[TBL] [Abstract][Full Text] [Related]
15. Surfactant Protein B Suppresses Lung Cancer Progression by Inhibiting Secretory Phospholipase A2 Activity and Arachidonic Acid Production.
Lee S; Kim D; Kang J; Kim E; Kim W; Youn H; Youn B
Cell Physiol Biochem; 2017; 42(4):1684-1700. PubMed ID: 28743125
[TBL] [Abstract][Full Text] [Related]
16. Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases.
Miyawaki E; Kenmotsu H; Mori K; Harada H; Mitsuya K; Mamesaya N; Kawamura T; Kobayashi H; Nakashima K; Omori S; Wakuda K; Ono A; Naito T; Murakami H; Endo M; Nakasu Y; Gon Y; Takahashi T
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):604-613. PubMed ID: 30851347
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study.
Zhai X; Li W; Li J; Jia W; Jing W; Tian Y; Xu S; Li Y; Zhu H; Yu J
Radiat Oncol; 2021 Dec; 16(1):233. PubMed ID: 34865626
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.
Halasz LM; Uno H; Hughes M; D'Amico T; Dexter EU; Edge SB; Hayman JA; Niland JC; Otterson GA; Pisters KM; Theriault R; Weeks JC; Punglia RS
Cancer; 2016 Jul; 122(13):2091-100. PubMed ID: 27088755
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery.
Yang WC; Xiao F; Shih JY; Ho CC; Chen YF; Tseng HM; Chen KY; Liao WY; Yu CJ; Yang JC; Kuo SH; Cheng JC; Yang PC; Hsu FM
Radiother Oncol; 2018 Feb; 126(2):368-374. PubMed ID: 29111173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
